RECIPIENT SCIENTIST. The name and address of this party will be specified in an implementing letter.
RECIPIENT SCIENTIST. The scientist employed by the RECIPIENT, receiving the ORIGINAL MATERIAL. The name and address of this party will be identified at the end of the AGREEMENT.
RECIPIENT SCIENTIST. The name is specified on the first page of the MTA.
RECIPIENT SCIENTIST. The name and address of this party is specified in the Record of Transfer, using Exhibit B to this Agreement.
RECIPIENT SCIENTIST. XXXNAME/XXXADDRESS Research Purpose: the experiments planned with the Material are described in Annex 1.
RECIPIENT SCIENTIST. 4. The SUPPLIER will supply the MATERIALS listed on Annex 2 attached to this AGREEMENT (“MATERIAL”) under the following terms and conditions: OWNERSHIP of MATERIAL and relevant information
RECIPIENT SCIENTIST. 5. The SUPPLIER will supply the SPECIMENs or samples listed on Annex 2 attached to this agreement (“MATERIAL”), and the RECIPIENT accepts the MATERIAL subject to the following terms and conditions: Ownership of MATERIAL and relevant information
RECIPIENT SCIENTIST. Annex 1 Recipient’s Institution full name and place of business (VAT number if applicable): SOTIO Biotech a.s., Xxxxxxxxxx 0000/0, 000 00 Xxxxxx 0, xxx Xxxxx Xxxxxxxx VAT no.: CZ10900004 Recipient principal scientist’s name, telephone number and e-mail: Address to send the material to: SOTIO Biotech a.s., Xxxxxxxxxx 0000/0, 000 00 Xxxxxx 0, xxx Xxxxx Xxxxxxxx Recipient authorized official’s name, telephone number and e-mail: Same as above Provider’s principal scientist making available the Material (if known): Description of the Material: Sequence and material of mutated versions of humanized antibody and original targeting human prostate specific membrane antigen (PSMA): Original Aims of the intended experiments: Sequence of the humanized antibody will be used to produce monoclonal antibodies that will be evaluated in vitro to check for their potential use in a development of a novel antibody-drug conjugate targeting . Benchmark antibody will be included in the screening and the data will be provided to IBT
RECIPIENT SCIENTIST. Dr. Dxxxxx Xxxxxx
